Skip to main content
. 2023 Feb 15;17(6):884–893. doi: 10.5009/gnl220457

Table 5.

Incidence of Adverse Drug Reactions (Safety Set)

Fexuprazan Placebo (n=108) p-value
20 mg once a day (n=109) 10 mg twice a day (n=108)
Gastrointestinal disorders 2 (1.8) [3] 1 (0.9) [2] 2 (1.9) [2]
Abdominal distension 0 1 (0.9) [1] 0
Abdominal pain 1 (0.9) [1] 1 (0.9) [1] 0
Bowel habit change 1 (0.9) [1] 0 0
Diarrhea 0 0 2 (1.9) [2]
Dyspepsia 1 (0.9) [1] 0 0
Nervous system disorders 2 (1.8) [2] 0 0
Headache 1 (0.9) [1] 0 0
Somnolence 1 (0.9) [1] 0 0
Renal and urinary disorders 1 (0.9) [1] 0 0
Urinary calculus 1 (0.9) [1] 0 0
Laboratory abnormalities 0 2 (1.9) [2] 0
Liver enzyme elevation 0 1 (0.9) [1] 0
Leukopenia 0 1 (0.9) [1] 0
Total 4 (3.7) [6] 3 (2.8) [4] 2 (1.9) [2] 0.912

Data are presented as number (%) [case].